Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro

International Journal of Oncology

Volumn 38, Issue 5, 2011, Pages 1409-1419

  Kitoh, Yusuke ^a   Saio, Masanao ^b   Gotoh, Naoe ^a   Umemura, Naoki ^a   Nonaka, Kenichi ^a   Bai, Juncheng ^a   Vizkeleti, Laura ^c   Torocsik, Daniel ^c   Balazs, Margit ^c   Adany, Roza ^c   Takami, Tsuyoshi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cell signaling; Granulocyte macrophage colony stimulating factor; Macrophage colony stimulating factor receptor; Tumor associated macrophages

Indexed keywords

CD206 ANTIGEN; CD36 ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; MACROPHAGE DERIVED CHEMOKINE; PROTEIN P105; PROTEIN P50; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; SYNAPTOTAGMIN I; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CYTOKINE PRODUCTION; DENDRITIC CELL; IN VITRO STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGEN PRESENTATION; CELL LINE, TUMOR; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOTHERAPY; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 79955003754     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.960     Document Type: Article

References (52)

1. Gabrilovich DI, Bronte V, Chen SH, et al: The terminology issue for myeloid-derived suppressor cells. Cancer Res 67: 425-426, 2007.
2. Young MR, Newby M and Wepsic HT: Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res 47: 100-105, 1987. (Pubitemid 17002105)
3. Bronte V, Serafini P, Apolloni E, et al: Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunother 24: 431-446, 2001, 1997.
4. Gallina G, Dolcetti L, Serafini P, et al: Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 116: 2777-2790, 2006. (Pubitemid 44511641)
5. Bronte V, Apolloni E, Cabrelle A, et al: Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96: 3838-3846, 2000.
6. Young MR and Lathers DM: Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int J Immunopharmacol 21: 241-252, 1999. (Pubitemid 29241776)
7. Young MR, Aquino S and Young ME: Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. J Leukoc Biol 45: 262-273, 1989. (Pubitemid 19086865)
8. Young MR, Young ME and Wright MA: Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity. Int J Cancer 46: 245-250, 1990. (Pubitemid 20252084)
9. Rabinovich GA, Gabrilovich D and Sotomayor EM: Immuno-suppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25: 267-296, 2007. (Pubitemid 46697910)
10. Mantovani A, Bottazzi B, Colotta F, et al: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992.
11. Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612, 2006. (Pubitemid 43165918)
12. Komohara Y, Ohnishi K, Kuratsu J, et al: Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216: 15-24, 2008.
13. Sahai E, Wyckoff J, Philippar U, et al: Simultaneous imaging of GFP, CFP and collagen in tumors in vivo using multiphoton microscopy. BMC Biotechnol 5: 14, 2005.
14. Wyckoff J, Wang W, Lin EY, et al: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022-7029, 2004. (Pubitemid 39331012)
15. Wyckoff JB, Wang Y, Lin EY, et al: Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67: 2649-2656, 2007. (Pubitemid 46548952)
16. Xue C, Wyckoff J, Liang F, et al: Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res 66: 192-197, 2006. (Pubitemid 43166025)
17. Nakagawa J, Saio M, Tamakawa N, et al: TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma. Int J Oncol 30: 803-811, 2007.
18. Stout RD, Jiang C, Matta B, et al: Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175: 342-349, 2005. (Pubitemid 40884337)
19. Stout RD and Suttles J: Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76: 509-513, 2004. (Pubitemid 39129080)
20. Dominguez PM and Ardavin C: Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev 234: 90-104, 2010.
21. Nonaka K, Saio M, Suwa T, et al: Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. J Leukoc Biol 84: 679-688, 2008.
22. Umemura N, Saio M, Suwa T, et al: Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukoc Biol 83: 1136-1144, 2008. (Pubitemid 351960345)
23. Mantovani A, Sozzani S, Locati M, et al: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002. (Pubitemid 35223554)
24. Banyer JL and Hapel AJ: Myb-transformed hematopoietic cells as a model for monocyte differentiation into dendritic cells and macrophages. J Leukoc Biol 66: 217-223, 1999. (Pubitemid 29379158)
25. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 3: 23-35, 2003.
26. Biswas SK, Gangi L, Paul S, et al: A distinct and unique transcriptional program expressed by tumor-associated macro-phages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 107: 2112-2122, 2006. (Pubitemid 43289397)
27. Hagemann T, Lawrence T, McNeish I, et al: 'Re-educating' tumor-associated macrophages by targeting NF-kappaB. J Exp Med 205: 1261-1268, 2008. (Pubitemid 351831483)
28. Conti L and Gessani S: GM-CSF in the generation of dendritic cells from human blood monocyte precursors: recent advances. Immunobiology 213: 859-870, 2008.
29. + progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells. J Immunother 23: 48-58, 2000.
30. Chapuis F, Rosenzwajg M, Yagello M, et al: Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27: 431-441, 1997. (Pubitemid 27085247)
31. Fujii S, Takayama T, Asakura M, et al: Dendritic cell-based cancer immunotherapies. Arch Immunol Ther Exp (Warsz) 57: 189-198, 2009.
32. Gilboa E: DC-based cancer vaccines. J Clin Invest 117: 1195-1203, 2007.
33. Hamilton JA: CSF-1 and cell cycle control in macrophages. Mol Reprod Dev 46: 19-23, 1997.
34. Naito M, Umeda S, Takahashi K, et al: Macrophage differentiation and granulomatous inflammation in osteopetrotic mice (op/op) defective in the production of CSF-1. Mol Reprod Dev 46: 85-91, 1997. (Pubitemid 27021358)
35. Jose MD, Le MY, Atkins RC, et al: Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant 3: 294-300, 2003. (Pubitemid 36407047)
36. Irvine KM, Burns CJ, Wilks AF, et al: A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations. FASEB J 20: 1921-1923, 2006.
37. Yu W, Chen J, Xiong Y, et al: CSF-1 receptor structure/function in MacCsf1r-/- macrophages: regulation of proliferation, differentiation, and morphology. J Leukoc Biol 84: 852-863, 2008.
38. Le MY, Tesch GH, Hill PA, et al: Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol 72: 530-537, 2002.
39. Valk E, Zahn S, Knop J, et al: JAK/STAT pathways are not involved in the direct activation of antigen-presenting cells by contact sensitizers. Arch Dermatol Res 294: 163-167, 2002. (Pubitemid 34744002)
40. Jackson SH, Yu CR, Mahdi RM, et al: Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol 172: 2307-2315, 2004. (Pubitemid 38182378)
41. Welte T, Koch F, Schuler G, et al: Granulocyte-macrophage colony-stimulating factor induces a unique set of STAT factors in murine dendritic cells. Eur J Immunol 27: 2737-2740, 1997. (Pubitemid 27453868)
42. Chomarat P, Banchereau J, Davoust J, et al: IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1: 510-514, 2000.
43. Kusmartsev S and Gabrilovich DI: STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J Immunol 174: 4880-4891, 2005.
44. Biswas SK and Lewis CE: NF-kappaB as a central regulator of macrophage function in tumors. J Leukoc Biol 88: 877-884, 2010.
45. Hagemann T, Biswas SK, Lawrence T, et al: Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood 113: 3139-3146, 2009.
46. Saccani A, Schioppa T, Porta C, et al: p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 66: 11432-11440, 2006. (Pubitemid 46009975)
47. Biswas SK, Sica A and Lewis CE: Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol 180: 2011-2017, 2008.
48. Nicoletti A, Caligiuri G, Tornberg I, et al: The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur J Immunol 29: 512-521, 1999. (Pubitemid 29078511)
49. Ceddia MA and Woods JA: Exercise suppresses macrophage antigen presentation. J Appl Physiol 87: 2253-2258, 1999.
50. Kondo H, Hazama S, Kawaoka T, et al: Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes. Anticancer Res 28: 379-387, 2008. (Pubitemid 351362841)
51. Bucala R and Donnelly SC: Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26: 281-285, 2007. (Pubitemid 46413914)
52. Mantovani A, Allavena P and Sica A: Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer 40: 1660-1667, 2004. (Pubitemid 38902900)